Inada Toshifumi, Beckmann Roland
Division of RNA and Gene Regulation, Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo 108-8639, Japan.
Gene Center and Department of Biochemistry, Feodor-Lynen-Str. 25, University of Munich, 81377 Munich, Germany.
J Mol Biol. 2024 Mar 15;436(6):168496. doi: 10.1016/j.jmb.2024.168496. Epub 2024 Feb 15.
Stalling of ribosomes engaged in protein synthesis can lead to significant defects in the function of newly synthesized proteins and thereby impair protein homeostasis. Consequently, partially synthesized polypeptides resulting from translation stalling are recognized and eliminated by several quality control mechanisms. First, if translation elongation reactions are halted prematurely, a quality control mechanism called ribosome-associated quality control (RQC) initiates the ubiquitination of the nascent polypeptide chain and subsequent proteasomal degradation. Additionally, when ribosomes with defective codon recognition or peptide-bond formation stall during translation, a quality control mechanism known as non-functional ribosomal RNA decay (NRD) leads to the degradation of malfunctioning ribosomes. In both of these quality control mechanisms, E3 ubiquitin ligases selectively recognize ribosomes in distinct translation-stalling states and ubiquitinate specific ribosomal proteins. Significant efforts have been devoted to characterize E3 ubiquitin ligase sensing of ribosome 'collision' or 'stalling' and subsequent ribosome is rescued. This article provides an overview of our current understanding of the molecular mechanisms and physiological functions of ribosome dynamics control and quality control of abnormal translation.
J Mol Biol. 2024-3-15
Mol Cell. 2022-4-21
Nucleic Acids Res. 2021-2-26
Nat Commun. 2017-7-31
Wiley Interdiscip Rev RNA. 2023
Biochem Soc Trans. 2025-6-30
Mol Syst Biol. 2025-5-27
J R Soc Interface. 2025-3
Nucleic Acids Res. 2025-2-8
Mol Cancer. 2025-1-31